CN Stock MarketDetailed Quotes

Zhejiang Shouxiangu Pharmaceutical (603896)

Watchlist
  • 16.19
  • -0.24-1.46%
Trading May 20 11:09 CST
3.21BMarket Cap-279.14P/E (TTM)

Zhejiang Shouxiangu Pharmaceutical (603896) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
-11.18%649.75M
-8.86%778.39M
-19.07%697.43M
-25.12%820.26M
-54.89%731.5M
-43.21%854.03M
-39.27%861.8M
-35.42%1.1B
-0.16%1.62B
-1.36%1.5B
Transactional financial assets
11.36%408.33M
3.33%356.16M
26.35%381.8M
40.54%379.45M
--366.67M
--344.69M
--302.17M
--270M
----
----
Notes receivable and accounts receivable
-16.71%101.76M
-19.02%92.18M
-33.96%80.76M
-29.94%86.34M
-25.67%122.17M
1.69%113.83M
2.40%122.28M
12.60%123.24M
29.50%164.35M
-18.68%111.93M
-Notes receivable
-34.56%28.05M
-34.87%20.88M
-45.60%16.6M
28.23%32.1M
126.34%42.87M
53.78%32.06M
113.78%30.52M
4.33%25.04M
-50.50%18.94M
-13.10%20.84M
-Accounts receivable
-7.05%73.71M
-12.80%71.3M
-30.08%64.15M
-44.77%54.23M
-45.47%79.3M
-10.23%81.77M
-12.72%91.76M
14.93%98.2M
64.03%145.41M
-19.86%91.09M
Other receivables (including interest and dividends)
3.10%3.81M
22.66%3.87M
9.68%4.71M
3.35%4.21M
-19.67%3.7M
-3.13%3.15M
8.19%4.29M
-29.94%4.07M
28.83%4.6M
29.63%3.25M
-Other receivable
----
22.66%3.87M
----
3.35%4.21M
----
-3.13%3.15M
----
-29.94%4.07M
----
29.63%3.25M
Advance payment
-28.82%8.7M
11.64%10.54M
-8.35%15.96M
-1.85%10.2M
1.25%12.22M
-54.31%9.44M
34.54%17.41M
-27.81%10.4M
-20.56%12.07M
47.91%20.66M
Inventories
11.33%219.74M
14.98%208.91M
8.81%236.35M
8.67%224.98M
18.62%197.37M
15.12%181.69M
21.01%217.21M
11.73%207.03M
0.93%166.39M
6.82%157.83M
Receivable financing
45.70%1.82M
113.59%1.9M
41.96%856.61K
154.92%838.69K
-9.28%1.25M
-21.22%891.83K
49.56%603.42K
-9.78%329K
346.51%1.38M
3,396.58%1.13M
Other current assets
108.33%21.15M
43.84%18.6M
117.52%18.85M
48.36%15.96M
-15.68%10.15M
60.15%12.93M
11.01%8.67M
318.80%10.75M
220.27%12.04M
49.88%8.08M
Adjustment items of current assets
----
----
----
----
----
----
----
----
--0.01
----
Total current assets
-2.07%1.42B
-3.30%1.47B
-6.37%1.44B
-10.40%1.54B
-27.11%1.45B
-15.84%1.52B
-11.97%1.53B
-14.55%1.72B
0.69%1.98B
-2.96%1.81B
Non Current assets
Other equity investment
6.37%96.63M
8.99%97.93M
10.14%90.96M
37.80%103.55M
25.21%90.85M
49.81%89.85M
31.69%82.59M
19.50%75.14M
14.98%72.56M
6.39%59.98M
Investment real estate
-5.53%162.27M
-5.58%164.7M
-22.45%167.14M
-22.39%169.57M
-22.21%171.76M
-22.04%174.44M
-5.09%215.54M
-5.03%218.49M
-5.26%220.8M
15.12%223.76M
Long-term equity investment
-6.51%4.65M
-5.17%4.74M
4.40%4.86M
-13.79%4.92M
-15.56%4.98M
-12.80%5M
-15.47%4.66M
4.76%5.71M
-1.54%5.9M
-3.20%5.74M
Fixed assets
----
148.52%852.69M
----
124.73%720.58M
----
2.42%343.11M
----
-7.77%320.64M
----
-11.13%335.01M
Constru in process
----
-61.59%192.72M
----
-39.50%242.06M
----
79.05%501.72M
----
176.79%400.07M
----
65.19%280.21M
Productive biological assets
-12.99%29.98M
-12.93%26.59M
-7.45%25.94M
9.30%32.25M
-1.11%34.46M
-2.71%30.53M
-8.19%28.03M
-11.95%29.5M
-1.98%34.84M
4.01%31.38M
Intangible assets
0.68%351.95M
0.40%354.28M
-0.80%352.98M
288.91%347.13M
298.32%349.57M
13.47%352.86M
13.41%355.83M
-5.86%89.26M
-8.35%87.76M
297.88%310.98M
Long deferred expense
10.05%68.61M
7.26%73.81M
-29.64%44.58M
-19.78%56.31M
-17.21%62.35M
-13.75%68.82M
38.13%63.36M
44.75%70.19M
49.85%75.31M
50.15%79.78M
Deferred tax assets
--1.65M
--1.69M
----
----
----
----
----
----
----
----
Usufruct assets
-6.79%37.4M
-4.67%39.1M
-4.63%39.11M
3.85%41.3M
16.44%40.12M
14.81%41.01M
16.27%41.01M
6.91%39.77M
42.91%34.46M
46.49%35.72M
Other non current assets
-58.23%4.87M
-28.33%2.72M
100.18%5.66M
-97.26%3.74M
-80.79%11.65M
-23.40%3.79M
-76.60%2.83M
1,691.46%136.64M
804.28%60.65M
38.97%4.95M
Total non current assets
7.94%1.8B
12.40%1.81B
13.02%1.72B
24.25%1.72B
34.42%1.67B
17.82%1.61B
23.17%1.52B
36.87%1.39B
22.34%1.24B
37.55%1.37B
Adjustment items of total assets
----
----
----
----
---0.01
----
----
----
----
----
Total assets
3.30%3.22B
4.78%3.28B
3.28%3.15B
5.05%3.26B
-3.40%3.12B
-1.34%3.13B
2.60%3.05B
2.65%3.11B
8.06%3.23B
11.14%3.17B
Liabilities
Current liabilities
Short term loan
47.69%140M
3.54%194.04M
-20.56%155.6M
6.80%262.92M
-75.95%94.79M
-49.65%187.4M
-41.00%195.87M
-33.02%246.18M
15.18%394.23M
36.34%372.16M
Notes payable and accounts payable
-17.82%130.8M
16.23%160.32M
20.88%146.85M
-1.39%165.52M
63.94%159.16M
-5.40%137.94M
4.02%121.48M
2.78%167.84M
-33.47%97.08M
1.29%145.82M
-Accounts payable
-17.82%130.8M
16.23%160.32M
20.88%146.85M
-1.39%165.52M
63.94%159.16M
-5.40%137.94M
4.02%121.48M
2.78%167.84M
-33.47%97.08M
1.29%145.82M
Contract liabilities
10.73%13.15M
35.56%14.32M
24.68%14.16M
43.32%13.91M
12.55%11.87M
17.69%10.56M
12.89%11.36M
11.47%9.7M
20.18%10.55M
8.37%8.98M
Advance receipts
21.21%1.22M
-45.65%639.26K
-13.44%1.02M
-38.25%895.46K
-25.53%1.01M
4.21%1.18M
50.57%1.18M
27.93%1.45M
-17.11%1.35M
50.17%1.13M
Salaries payable
19.82%21.46M
2.24%27.38M
-3.72%25.03M
-1.18%22.16M
-2.78%17.91M
-7.94%26.78M
-12.81%26M
-8.70%22.42M
-4.05%18.42M
-9.32%29.09M
Taxs payable
7,206.47%121.82M
1,475.54%122.76M
2.63%8.62M
23.62%4.2M
-76.11%1.67M
-18.25%7.79M
-3.08%8.4M
-2.50%3.4M
48.05%6.98M
16.01%9.53M
Other payable (including interest and dividends)
21.87%5.03M
93.09%7.22M
91.73%5.26M
19.63%3.39M
-43.60%4.13M
-30.28%3.74M
-0.58%2.74M
-92.55%2.84M
184.51%7.32M
-6.35%5.36M
-Other payable
----
93.09%7.22M
----
19.63%3.39M
----
-30.28%3.74M
----
-6.45%2.84M
----
-6.35%5.36M
Non current liabilities due within one year
33.88%16.72M
4.07%17.45M
35.45%14.13M
35.43%14.47M
57.65%12.49M
38.80%16.77M
6.28%10.43M
5.94%10.68M
44.81%7.92M
147.88%12.08M
Other current liabilities
-8.63%1.3M
45.84%1.7M
378.72%5.72M
342.26%4.72M
24.59%1.43M
16.81%1.17M
6.94%1.2M
9.57%1.07M
16.18%1.15M
9.90%1M
Total current liabilities
48.30%451.51M
38.77%545.83M
-0.59%376.4M
5.71%492.19M
-44.14%304.46M
-32.78%393.33M
-26.02%378.65M
-24.65%465.58M
2.53%545.01M
22.48%585.15M
Current liabilities
Bonds payable
5.95%389.08M
5.95%382.49M
6.12%379.96M
6.12%373.55M
6.12%367.24M
6.12%361.01M
6.46%358.05M
6.46%352.01M
-17.54%346.05M
-17.55%340.19M
Deferred tax liabilities
10.98%9.44M
14.93%9.64M
21.70%8.6M
75.48%10.56M
57.43%8.51M
122.03%8.39M
76.24%7.07M
45.53%6.02M
30.57%5.4M
24.10%3.78M
Long term deferred income
6.94%58.72M
13.25%62.13M
6.96%54.12M
6.19%52.36M
19.08%54.91M
9.76%54.86M
18.13%50.6M
25.36%49.31M
12.77%46.11M
21.03%49.98M
Lease liabilities
-31.85%18.66M
-8.43%21M
-19.17%22.81M
-10.49%23.3M
14.97%27.38M
-4.33%22.93M
19.54%28.21M
4.29%26.04M
62.08%23.81M
50.09%23.97M
Total non current liabilities
3.90%475.9M
6.28%475.26M
4.86%465.49M
6.09%459.77M
8.70%458.03M
7.00%447.19M
9.14%443.94M
8.59%433.37M
-12.10%421.38M
-11.63%417.92M
Total liabilities
21.63%927.41M
21.48%1.02B
2.35%841.89M
5.90%951.96M
-21.10%762.49M
-16.20%840.52M
-10.45%822.58M
-11.60%898.96M
-4.41%966.39M
5.51%1B
Shareholders equity
Paid-in capital
0.00%198.24M
0.00%198.24M
0.00%198.24M
-1.78%198.24M
-1.78%198.24M
-1.78%198.24M
-1.78%198.24M
0.00%201.83M
2.34%201.83M
2.35%201.83M
Other equity instruments
-0.00%69.77M
-0.00%69.77M
-0.00%69.77M
-0.00%69.77M
-0.00%69.77M
-0.00%69.77M
-0.00%69.77M
-0.00%69.77M
-21.30%69.77M
-21.30%69.77M
Capital reserve funds
1.70%818.22M
-0.40%818.22M
1.70%818.22M
-15.30%818.22M
-16.72%804.52M
-14.96%821.52M
-16.72%804.52M
0.00%966.03M
12.81%966.03M
12.82%966.03M
Surplus reserve funds
0.00%100.93M
0.00%100.93M
0.00%100.93M
0.00%100.93M
0.00%100.93M
0.00%100.93M
8.90%100.93M
8.90%100.93M
8.90%100.93M
8.90%100.93M
Retained profit
-7.34%1.05B
-3.38%1.02B
5.82%1.08B
6.63%1.06B
7.48%1.13B
7.97%1.05B
17.08%1.02B
21.93%998.33M
19.76%1.05B
19.49%974.77M
Less:Treasury stock
----
----
----
----
----
----
----
0.00%165.11M
0.00%165.11M
0.00%165.11M
Other composite income
10.42%54.35M
14.63%55.46M
16.64%49.33M
66.96%60.04M
45.81%49.22M
109.83%48.38M
66.15%42.29M
40.48%35.96M
30.91%33.76M
14.91%23.06M
Shareholders equity without minority interests
-2.73%2.29B
-1.39%2.26B
3.58%2.31B
4.71%2.31B
4.17%2.35B
5.53%2.29B
8.42%2.23B
9.86%2.21B
14.45%2.26B
13.95%2.17B
Minority interests
--1.9M
--925.86K
--984.48K
----
----
----
----
----
----
----
Total shareholder equity
-2.65%2.29B
-1.35%2.26B
3.62%2.31B
4.71%2.31B
4.17%2.35B
5.53%2.29B
8.42%2.23B
9.86%2.21B
14.45%2.26B
13.95%2.17B
Total liabilityies and equity
3.30%3.22B
4.78%3.28B
3.28%3.15B
5.05%3.26B
-3.40%3.12B
-1.34%3.13B
2.60%3.05B
2.65%3.11B
8.06%3.23B
11.14%3.17B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds -11.18%649.75M-8.86%778.39M-19.07%697.43M-25.12%820.26M-54.89%731.5M-43.21%854.03M-39.27%861.8M-35.42%1.1B-0.16%1.62B-1.36%1.5B
Transactional financial assets 11.36%408.33M3.33%356.16M26.35%381.8M40.54%379.45M--366.67M--344.69M--302.17M--270M--------
Notes receivable and accounts receivable -16.71%101.76M-19.02%92.18M-33.96%80.76M-29.94%86.34M-25.67%122.17M1.69%113.83M2.40%122.28M12.60%123.24M29.50%164.35M-18.68%111.93M
-Notes receivable -34.56%28.05M-34.87%20.88M-45.60%16.6M28.23%32.1M126.34%42.87M53.78%32.06M113.78%30.52M4.33%25.04M-50.50%18.94M-13.10%20.84M
-Accounts receivable -7.05%73.71M-12.80%71.3M-30.08%64.15M-44.77%54.23M-45.47%79.3M-10.23%81.77M-12.72%91.76M14.93%98.2M64.03%145.41M-19.86%91.09M
Other receivables (including interest and dividends) 3.10%3.81M22.66%3.87M9.68%4.71M3.35%4.21M-19.67%3.7M-3.13%3.15M8.19%4.29M-29.94%4.07M28.83%4.6M29.63%3.25M
-Other receivable ----22.66%3.87M----3.35%4.21M-----3.13%3.15M-----29.94%4.07M----29.63%3.25M
Advance payment -28.82%8.7M11.64%10.54M-8.35%15.96M-1.85%10.2M1.25%12.22M-54.31%9.44M34.54%17.41M-27.81%10.4M-20.56%12.07M47.91%20.66M
Inventories 11.33%219.74M14.98%208.91M8.81%236.35M8.67%224.98M18.62%197.37M15.12%181.69M21.01%217.21M11.73%207.03M0.93%166.39M6.82%157.83M
Receivable financing 45.70%1.82M113.59%1.9M41.96%856.61K154.92%838.69K-9.28%1.25M-21.22%891.83K49.56%603.42K-9.78%329K346.51%1.38M3,396.58%1.13M
Other current assets 108.33%21.15M43.84%18.6M117.52%18.85M48.36%15.96M-15.68%10.15M60.15%12.93M11.01%8.67M318.80%10.75M220.27%12.04M49.88%8.08M
Adjustment items of current assets ----------------------------------0.01----
Total current assets -2.07%1.42B-3.30%1.47B-6.37%1.44B-10.40%1.54B-27.11%1.45B-15.84%1.52B-11.97%1.53B-14.55%1.72B0.69%1.98B-2.96%1.81B
Non Current assets
Other equity investment 6.37%96.63M8.99%97.93M10.14%90.96M37.80%103.55M25.21%90.85M49.81%89.85M31.69%82.59M19.50%75.14M14.98%72.56M6.39%59.98M
Investment real estate -5.53%162.27M-5.58%164.7M-22.45%167.14M-22.39%169.57M-22.21%171.76M-22.04%174.44M-5.09%215.54M-5.03%218.49M-5.26%220.8M15.12%223.76M
Long-term equity investment -6.51%4.65M-5.17%4.74M4.40%4.86M-13.79%4.92M-15.56%4.98M-12.80%5M-15.47%4.66M4.76%5.71M-1.54%5.9M-3.20%5.74M
Fixed assets ----148.52%852.69M----124.73%720.58M----2.42%343.11M-----7.77%320.64M-----11.13%335.01M
Constru in process -----61.59%192.72M-----39.50%242.06M----79.05%501.72M----176.79%400.07M----65.19%280.21M
Productive biological assets -12.99%29.98M-12.93%26.59M-7.45%25.94M9.30%32.25M-1.11%34.46M-2.71%30.53M-8.19%28.03M-11.95%29.5M-1.98%34.84M4.01%31.38M
Intangible assets 0.68%351.95M0.40%354.28M-0.80%352.98M288.91%347.13M298.32%349.57M13.47%352.86M13.41%355.83M-5.86%89.26M-8.35%87.76M297.88%310.98M
Long deferred expense 10.05%68.61M7.26%73.81M-29.64%44.58M-19.78%56.31M-17.21%62.35M-13.75%68.82M38.13%63.36M44.75%70.19M49.85%75.31M50.15%79.78M
Deferred tax assets --1.65M--1.69M--------------------------------
Usufruct assets -6.79%37.4M-4.67%39.1M-4.63%39.11M3.85%41.3M16.44%40.12M14.81%41.01M16.27%41.01M6.91%39.77M42.91%34.46M46.49%35.72M
Other non current assets -58.23%4.87M-28.33%2.72M100.18%5.66M-97.26%3.74M-80.79%11.65M-23.40%3.79M-76.60%2.83M1,691.46%136.64M804.28%60.65M38.97%4.95M
Total non current assets 7.94%1.8B12.40%1.81B13.02%1.72B24.25%1.72B34.42%1.67B17.82%1.61B23.17%1.52B36.87%1.39B22.34%1.24B37.55%1.37B
Adjustment items of total assets -------------------0.01--------------------
Total assets 3.30%3.22B4.78%3.28B3.28%3.15B5.05%3.26B-3.40%3.12B-1.34%3.13B2.60%3.05B2.65%3.11B8.06%3.23B11.14%3.17B
Liabilities
Current liabilities
Short term loan 47.69%140M3.54%194.04M-20.56%155.6M6.80%262.92M-75.95%94.79M-49.65%187.4M-41.00%195.87M-33.02%246.18M15.18%394.23M36.34%372.16M
Notes payable and accounts payable -17.82%130.8M16.23%160.32M20.88%146.85M-1.39%165.52M63.94%159.16M-5.40%137.94M4.02%121.48M2.78%167.84M-33.47%97.08M1.29%145.82M
-Accounts payable -17.82%130.8M16.23%160.32M20.88%146.85M-1.39%165.52M63.94%159.16M-5.40%137.94M4.02%121.48M2.78%167.84M-33.47%97.08M1.29%145.82M
Contract liabilities 10.73%13.15M35.56%14.32M24.68%14.16M43.32%13.91M12.55%11.87M17.69%10.56M12.89%11.36M11.47%9.7M20.18%10.55M8.37%8.98M
Advance receipts 21.21%1.22M-45.65%639.26K-13.44%1.02M-38.25%895.46K-25.53%1.01M4.21%1.18M50.57%1.18M27.93%1.45M-17.11%1.35M50.17%1.13M
Salaries payable 19.82%21.46M2.24%27.38M-3.72%25.03M-1.18%22.16M-2.78%17.91M-7.94%26.78M-12.81%26M-8.70%22.42M-4.05%18.42M-9.32%29.09M
Taxs payable 7,206.47%121.82M1,475.54%122.76M2.63%8.62M23.62%4.2M-76.11%1.67M-18.25%7.79M-3.08%8.4M-2.50%3.4M48.05%6.98M16.01%9.53M
Other payable (including interest and dividends) 21.87%5.03M93.09%7.22M91.73%5.26M19.63%3.39M-43.60%4.13M-30.28%3.74M-0.58%2.74M-92.55%2.84M184.51%7.32M-6.35%5.36M
-Other payable ----93.09%7.22M----19.63%3.39M-----30.28%3.74M-----6.45%2.84M-----6.35%5.36M
Non current liabilities due within one year 33.88%16.72M4.07%17.45M35.45%14.13M35.43%14.47M57.65%12.49M38.80%16.77M6.28%10.43M5.94%10.68M44.81%7.92M147.88%12.08M
Other current liabilities -8.63%1.3M45.84%1.7M378.72%5.72M342.26%4.72M24.59%1.43M16.81%1.17M6.94%1.2M9.57%1.07M16.18%1.15M9.90%1M
Total current liabilities 48.30%451.51M38.77%545.83M-0.59%376.4M5.71%492.19M-44.14%304.46M-32.78%393.33M-26.02%378.65M-24.65%465.58M2.53%545.01M22.48%585.15M
Current liabilities
Bonds payable 5.95%389.08M5.95%382.49M6.12%379.96M6.12%373.55M6.12%367.24M6.12%361.01M6.46%358.05M6.46%352.01M-17.54%346.05M-17.55%340.19M
Deferred tax liabilities 10.98%9.44M14.93%9.64M21.70%8.6M75.48%10.56M57.43%8.51M122.03%8.39M76.24%7.07M45.53%6.02M30.57%5.4M24.10%3.78M
Long term deferred income 6.94%58.72M13.25%62.13M6.96%54.12M6.19%52.36M19.08%54.91M9.76%54.86M18.13%50.6M25.36%49.31M12.77%46.11M21.03%49.98M
Lease liabilities -31.85%18.66M-8.43%21M-19.17%22.81M-10.49%23.3M14.97%27.38M-4.33%22.93M19.54%28.21M4.29%26.04M62.08%23.81M50.09%23.97M
Total non current liabilities 3.90%475.9M6.28%475.26M4.86%465.49M6.09%459.77M8.70%458.03M7.00%447.19M9.14%443.94M8.59%433.37M-12.10%421.38M-11.63%417.92M
Total liabilities 21.63%927.41M21.48%1.02B2.35%841.89M5.90%951.96M-21.10%762.49M-16.20%840.52M-10.45%822.58M-11.60%898.96M-4.41%966.39M5.51%1B
Shareholders equity
Paid-in capital 0.00%198.24M0.00%198.24M0.00%198.24M-1.78%198.24M-1.78%198.24M-1.78%198.24M-1.78%198.24M0.00%201.83M2.34%201.83M2.35%201.83M
Other equity instruments -0.00%69.77M-0.00%69.77M-0.00%69.77M-0.00%69.77M-0.00%69.77M-0.00%69.77M-0.00%69.77M-0.00%69.77M-21.30%69.77M-21.30%69.77M
Capital reserve funds 1.70%818.22M-0.40%818.22M1.70%818.22M-15.30%818.22M-16.72%804.52M-14.96%821.52M-16.72%804.52M0.00%966.03M12.81%966.03M12.82%966.03M
Surplus reserve funds 0.00%100.93M0.00%100.93M0.00%100.93M0.00%100.93M0.00%100.93M0.00%100.93M8.90%100.93M8.90%100.93M8.90%100.93M8.90%100.93M
Retained profit -7.34%1.05B-3.38%1.02B5.82%1.08B6.63%1.06B7.48%1.13B7.97%1.05B17.08%1.02B21.93%998.33M19.76%1.05B19.49%974.77M
Less:Treasury stock ----------------------------0.00%165.11M0.00%165.11M0.00%165.11M
Other composite income 10.42%54.35M14.63%55.46M16.64%49.33M66.96%60.04M45.81%49.22M109.83%48.38M66.15%42.29M40.48%35.96M30.91%33.76M14.91%23.06M
Shareholders equity without minority interests -2.73%2.29B-1.39%2.26B3.58%2.31B4.71%2.31B4.17%2.35B5.53%2.29B8.42%2.23B9.86%2.21B14.45%2.26B13.95%2.17B
Minority interests --1.9M--925.86K--984.48K----------------------------
Total shareholder equity -2.65%2.29B-1.35%2.26B3.62%2.31B4.71%2.31B4.17%2.35B5.53%2.29B8.42%2.23B9.86%2.21B14.45%2.26B13.95%2.17B
Total liabilityies and equity 3.30%3.22B4.78%3.28B3.28%3.15B5.05%3.26B-3.40%3.12B-1.34%3.13B2.60%3.05B2.65%3.11B8.06%3.23B11.14%3.17B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More